Carmine De Angelis

Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up

Luca Malorni, Priya B. Shetty, Carmine De Angelis et al. · Breast Cancer Research and Treatment · 2012 · 266 citations

Medicine, Cancer Biology, Oncology +16

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Xiaoyong Fu, Rinath Jeselsohn, Resel Pereira et al. · Proceedings of the National Academy of Sciences · 2016 · 184 citations · Full text

Medicine, Molecular Biology, Oncology +17

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Xiaoyong Fu, Resel Pereira, Carmine De Angelis et al. · Proceedings of the National Academy of Sciences · 2019 · 171 citations · Full text

Medicine, Genetics, Oncology +17

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Aleix Prat, Tomás Pascual, Carmine De Angelis et al. · JNCI Journal of the National Cancer Institute · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

Mingjun Bi, Zhao Zhang, Yi‐Zhou Jiang et al. · Nature Cell Biology · 2020 · 139 citations · Full text

Medicine, Genetics, Molecular Biology +17